Inotuzumab ozogamicin as a single agent to treat T315I-mutated chronic myeloid leukemia with acute blastic change to CD22+ acute lymphocytic leukemia
- Resource Type
- Source
- Journal of the Formosan Medical Association = Taiwan yi zhi.
- Subject
General Medicine - Language
- ISSN
- 0929-6646